PPARγ suppresses the growth and invasion of human colon [71] and gastric [72, 73] and esophageal carcinoma cells [74], and both PPARγ [75] and PPARα have anti-inflammatory actions [76]. Here, PPARG is linked to carcinoma of esophagus.